Arizona State University said this week that Raymond DuBois will take over as executive director of its Biodesign Institute on Dec. 1.
DuBois is currently provost and executive vice president and professor of cancer biology and cancer medicine at the University of Texas MD Anderson Cancer Center. Before that he was director of the Vanderbilt-Ingram Cancer Center at Vanderbilt University.
Waters this week named the Metabolomics Laboratory at the University of North Texas as a Waters Center of Innovation. The laboratory is directed by Vladimir Shulaev, who was cited by Waters for his work on metabolomics and metabolic signaling pathway research and teaching.
Shulaev's research focuses on plant metabolomics, and his lab is part of UNT's Plant Signaling Cluster, a group of researchers pursuing understanding of plant cellular communication. His is the 18th lab recognized by Waters as a Center of Innovation.
Personalized medicine and molecular diagnostics firm Nodality has appointed pharmaceutical, biotech, and venture capital executive Laura Brege to serve as company president and CEO.
Brege formerly was executive vice president and chief operating officer at Onyx Pharmaceuticals, and she was a general partner at Red Rock Capital Management. She also was senior vice president and chief financial officer at COR Therapeutics, chief financial officer at Flextronics, and treasurer of The Cooper Companies.